Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...
Zacks.com on MSN9h
Company News for Oct 4, 2024
Levi Strauss & Co.’s (LEVI) shares plunged 7.7% after reporting third-quarter fiscal 2024 net revenues of $1,517 million, missing the Zacks Consensus Estimate of $1,552 million. Shares of ...
Massive News for Hims & Hers Stock: The Truth About Today's Move
S hares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impac ...
2 Winning Growth Stocks That Are Screaming Buys Right Now
The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...